Haehner Antje, Hummel Thomas, Hummel Cornelia, Sommer Ulrike, Junghanns Susann, Reichmann Heinz
Department of Neurology, University of Dresden Medical School, Germany.
Mov Disord. 2007 Apr 30;22(6):839-42. doi: 10.1002/mds.21413.
Recent studies support the idea of olfactory dysfunction as a very early sign of idiopathic Parkinson's disease (IPD). Aim of the present study was to clinically follow-up patients with idiopathic hyposmia to find out the percentage of patients developing IPD after 4 years time. At baseline, olfactory tests had been combined with transcranial sonography of the substantia nigra and (123)I-FP-CIT SPECT imaging. At the present neurological examination, 7% of the individuals with idiopathic hyposmia had developed clinical IPD. Altogether, 13% presented with abnormalities of the motor system. Our data suggest that a combination of olfactory testing and other tests may constitute a screening tool for the risk to develop IPD.
近期研究支持嗅觉功能障碍是特发性帕金森病(IPD)非常早期迹象的观点。本研究的目的是对特发性嗅觉减退患者进行临床随访,以查明4年后发展为IPD的患者百分比。在基线时,嗅觉测试已与黑质的经颅超声检查以及(123)I-FP-CIT单光子发射计算机断层扫描成像相结合。在目前的神经学检查中,7%的特发性嗅觉减退个体已发展为临床IPD。总体而言,13%的个体存在运动系统异常。我们的数据表明,嗅觉测试与其他测试相结合可能构成一种用于评估发展为IPD风险的筛查工具。